Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

- Relapsing Multiple Sclerosis
- Terminated

Study Title: A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease Course

Teva Identifier: MS-LAQ-301E | 2009-012989-30

ClinicalTrials.gov Identifier: NCT00988052

Study Status: Terminated

Trial Condition(s): Relapsing Multiple Sclerosis

Interventions: Drug: Laquinimod

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 55 Years

Trial Duration: November 10, 2009 - July 1, 2017

Phase: Phase 3

Study Type

Interventional